Published in

Bentham Science Publishers, Letters in Drug Design & Discovery, 6(6), p. 403-412

DOI: 10.2174/157018009789057580

Links

Tools

Export citation

Search in Google Scholar

The Anticancer Activity of the N-Terminal CARD-Like Domain of Arginine Deiminase (ADI) from Pseudomonas aeruginosa

This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

While arginine deiminase (ADI) from Mycoplasma arginini is a well-known anticancer agent, very little is known about any such role of ADI from other bacteria. Additionally, M. arginini ADI is believed to exert its anticancer activity due to depletion of arginine from cancer cells. In this report, we demonstrate anticancer activity of ADI from Pseudomonas aeruginosa. We have also cloned and expressed a truncated form from the P. aeruginosa ADI which harbors a caspase recruitment domain (CARD). This polypeptide, called Pa-CARD, demonstrates anticancer activity without exhibiting any ADI enzymatic activity by inducing apoptosis in cancer cells but not in normal cells. Microarray experiments suggest that Pa-CARD modulates NF-kB signaling pathway genes to exert its anticancer activity.